Martingale Asset Management »

Mirum Pharmaceuticals shares owned by Martingale Asset Management

Quarter-by-quarter ownership of Mirum Pharmaceuticals (MIRM) shares owned by Martingale Asset Management from 13F filings

Historical chart of Martingale Asset Management investment in Mirum Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Mirum Pharmaceuticals held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirum Pharmaceuticals by Martingale Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.4M 18k 78.99

More positions owned by Martingale Asset Management

Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Cisco Systems (CSCO)
Facebook Inc cl a (META)
Berkshire Hathaway (BRK.B)
Visa (V)
Exxon Mobil Corporation (XOM)
Wal-Mart Stores (WMT)
NVIDIA Corporation (NVDA)
MasterCard Incorporated (MA)

View all positions for Martingale Asset Management

Top funds holding Mirum Pharmaceuticals

Frazier Life Sciences Management
Henderson Group
BlackRock
Vanguard Group
State Street Corporation
Eventide Asset Management
BVF
Novo A/S
Tang Capital Management
Citadel Advisors
Geode Capital Management
D. E. Shaw & Co
ClearBridge Advisors
Polar Capital Holdings
Wellington Management Company

View all funds holding Mirum Pharmaceuticals